Sergio Fersino

Ospedale Sacro Cuore Don Calabria

Papers

1

Total Citations

45

H-Index

1

About

Sergio Fersino is a leading radiation oncologist whose research centers on advanced radiotherapy techniques for prostate cancer, with a particular focus on hypofractionation and image-guided therapy. His most-cited work, a 2017 study on moderate hypofractionated postprostatectomy volumetric modulated arc therapy with daily image guidance (VMAT-IGRT), established the feasibility and safety of delivering higher daily radiation doses after surgery, demonstrating low acute toxicity in a mono-institutional cohort. This contribution has been cited 45 times, reflecting its influence on clinical protocols aiming to shorten treatment duration while maintaining efficacy. Fersino’s broader research portfolio explores stereotactic body radiotherapy (SBRT), adaptive planning, and toxicity mitigation strategies, positioning him as a key figure in optimizing prostate cancer management. His work has helped validate modern, patient-friendly approaches that reduce hospital visits without compromising outcomes, earning recognition among peers for its practical impact on daily practice. For students and researchers, Fersino exemplifies how rigorous clinical investigation can translate directly into improved patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity
45 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Ospedale Sacro Cuore Don Calabria

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago